Indobufen: Indication, Dosage, Side Effect, Precaution

This information is not country-specific. Please refer to the Malaysia prescribing information.

Generic Medicine Info

Indications and Dosage

Oral
Thromboembolic disorders

Adult: 200-400 mg/day in 2 divided doses. May also be given parenterally using the sodium salt.
Elderly: >65 yr: 100-200 mg/day.

Renal Impairment

100-200 mg/day.

Contraindications

GI ulceration, ulcerative colitis, active bleeding, haemophilia.

Special Precautions

Pregnancy, lactation.

Adverse Reactions

Haemostatic disorders, GI disturbances (diarrhoea, ulcer, bleeding).

Drug Interactions

Reduced absorption with antacids and cholestyramine.

Action

Description:
Mechanism of Action: Indobufen inhibits platelet aggregation by reversibly inhibiting the cyclo-oxygenase enzyme, resulting in suppressed thromboxane synthesis.
Pharmacokinetics:
Absorption: Rapidly absorbed; peak plasma concentrations in 2 hr.
Distribution: Protein-binding: 99%.
Metabolism: Hepatic.
Excretion: Via urine (75%, as metabolites and unchanged drug); 8 hr (plasma half-life).

MIMS Class

Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)

Disclaimer: This information is independently developed by MIMS based on Indobufen from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2024 MIMS. All rights reserved. Powered by MIMS.com